Skip to main content

EASD Annual Meeting 2020

Featured podcast

EASD 2020: Editorial Board conference highlights

Listen to Sanjay Kalra, John Wilding and Lori Berard reflecting on their research highlights of this year’s virtual 56th EASD Annual Meeting (39:05). 

Latest research news

10-07-2020 | EASD 2020 | Conference coverage | News

Acute eGFR decline with SGLT2 inhibitors does not affect outcome

The benefits of treatment with SGLT2 inhibitors are not negated by the initial decline in estimated glomerular filtration rate commonly seen with these drugs, show post-hoc analyses of the EMPA-REG OUTCOME and CREDENCE trials.

10-05-2020 | EASD 2020 | Conference coverage | News

Excess mortality problem is not shrinking in young people with type 1 diabetes

Absolute mortality rates are falling among younger people with type 1 diabetes, but excess mortality relative to the general population remains high and unchanged, show Scottish national registry data presented at the virtual 56th EASD Annual Meeting.

10-01-2020 | EASD 2020 | Conference coverage | News

​​​​​​​CAPTURE reveals CVD in a third of people with type 2 diabetes worldwide

The global CAPTURE study shows that one in three people with type 2 diabetes in 2019 had cardiovascular disease, but few were taking antidiabetes medications with proven cardioprotective ability.


Medicine Matters conference coverage is brought to you in partnership with medwireNews